Hers vs PlushCare
PlushCare costs $50 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →
PlushCare
Best for: coverage in all 50 states, which most sellers will not confirm
Visit PlushCare →If you are choosing between Hers and PlushCare, the first difference is cost: PlushCare is $50 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Hers leads our six-part score, 7.0 to 6.4.
Hers vs PlushCare price
PlushCare is the cheaper way in: $149 a month against $199 a month at Hers. That is $50 less each month (25% lower), or about $600 over a year of treatment.
Drug by drug: Semaglutide is cheaper at PlushCare ($149 a month vs $199 a month); tirzepatide is cheaper at Hers ($299 a month vs $399 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Hers prices compounded injections and brand-name pens, while PlushCare prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.
Where each one treats patients
Hers lists 50 states, and PlushCare lists 50 states.
They overlap in 50 states.
Pricing
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
PlushCare
Range up to $299/mo
Range up to $599/mo
What each price covers
Hers' price also covers the medication itself, which PlushCare does not claim.
Hers is silent on shipping and lab work.
PlushCare is silent on shipping and coaching.
That matters most for the drug: unless PlushCare confirms otherwise, budget for medication on top of its listed price.
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
PlushCare
Covered by the monthly price
Medication
Charged on top
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Charged on top
Coaching
Not stated
Where each one scores higher
Overall, Hers scores 7.0 and PlushCare 6.4 out of 10.
Hers is stronger on user experience (8.0 vs 7.0), trust & safety (8.5 vs 7.5) and support (3.0 vs 0.0).
Value, effectiveness and accessibility are within half a point.
Hers
7.0/10
PlushCare
6.4/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Hers nor PlushCare has an FDA warning letter on record with us.
Features & Coverage
| Feature | Hers | PlushCare |
|---|---|---|
| Starting Price | $199/mo | ✓$149/mo |
| Features | 2 features | ✓8 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →About PlushCare
PlushCare is an established virtual primary-care telehealth platform and a subsidiary of Transcarent, Inc., a Delaware corporation that also owns Accolade, 2nd.MD, and 98point6 by Transcarent. Virtual visits with US board-certified physicians cost $30 per appointment insured and $129 self-pay. GLP-1 prescribing is a clinician-discretionary option within the broader primary-care relationship.
Read our full PlushCare review →Pros & Cons
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- We found no FDA warning letters issued to Hers
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
PlushCare
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- Serves all 50 states
- We found no FDA warning letters issued to PlushCare
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
- Baseline bloodwork is required before a prescription
Watch-outs
- Not included in the monthly price: medication, clinician visits, lab work
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Hers wins this one, 7.0 to 6.4, above all for coverage in all 50 states, which most sellers will not confirm. PlushCare undercuts it by $50 a month, so if the monthly bill is what decides it, PlushCare is the pick. PlushCare fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Choose PlushCare if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Hers vs PlushCare: FAQ
Close alternatives to Hers and PlushCare
- Hers vs Hims
- Hers vs Noom
- Hers vs Care Bare Rx
- Hers vs Concierge MD LA
- PlushCare vs altRX
- PlushCare vs Trinity Meds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.